Literature DB >> 33033445

Saliva diagnostic utility in patients with type 2 diabetes: Future standard method.

Marwa Mrag1, Asma Kassab1, Asma Omezzine2, Chebil Raoua Belkacem1, Fredj Ismail Fatma Ben3, Nabiha Douki1, Kechrid Chedia Laouani3, Ali Bouslema2, Amor Faten Ben1.   

Abstract

BACKGROUND: The purpose of the present study was to assess saliva reliability in diagnosis and monitoring type 2 diabetes instead of blood.
METHODS: Blood and unstimulated whole saliva were collected from 300 type 2 diabetic subjects and 300 healthy controls in fasting. Then, the salivary flow rate was calculated. All parameters including glucose, urea, amylase, total protein, albumin, C-reactive protein (CRP), immunoglobulin A (IgA), potassium, calcium and chloride were assessed in the supernatant, using an autoanalyzer. Oral exam was conducted by a single examiner on full mouth excluding third molars. Statistical analysis was performed by the SPSS 20.0 version.
RESULTS: Saliva screening showed that glucose, urea, amylase, total protein, potassium, calcium and chloride were significantly higher in patients compared to controls (p < 0.05). Whereas, the IgA level and salivary flow rate were significantly reduced in patients (p < 0.05). No significant difference was found in albumin and CRP levels (p > 0.05). There was a significant positive correlation between salivary and plasma glucose levels (r = 0.887, and r = 0.900, p < 0.001), as well as, salivary and blood urea (r = 0.586, and r = 0.688, p < 0.001) in patients and controls, respectively.
CONCLUSIONS: From this study, saliva could be suggested as a useful diagnostic tool for type 2 diabetes. 2020 Marwa Mrag, Asma Kassab, Asma Omezzine, Chebil Raoua Belkacem, Fredj Ismail Fatma Ben, Nabiha Douki, Kechrid Chedia Laouani, Ali Bouslema, Amor Faten Ben, published by CEON/CEES.

Entities:  

Keywords:  glucose; saliva; type 2 diabetes; urea

Year:  2020        PMID: 33033445      PMCID: PMC7526023          DOI: 10.2478/jomb-2019-0019

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  34 in total

1.  Salivary IgA and periodontal treatment needs in diabetic patients.

Authors:  Luciana Salles Branco-de-Almeida; Cláudia Maria Coêlho Alves; Fernanda Ferreira Lopes; Adriana de Fátima Vasconcelos Pereira; Rosane Nassar Meireles Guerra; Antônio Luiz Amaral Pereira
Journal:  Braz Oral Res       Date:  2011 Nov-Dec

2.  Structural and functional salivary disorders in type 2 diabetic patients.

Authors:  Carmen Carda; Nezly Mosquera-Lloreda; Lucas Salom; Maria Elsa Gomez de Ferraris; Amando Peydró
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2006-07-01

3.  Correlation between serum urea and salivary urea.

Authors:  K T Sein; G Arumainayagam
Journal:  Clin Chem       Date:  1987-12       Impact factor: 8.327

4.  Estimation of salivary sodium, potassium, calcium, phosphorus and urea in type II diabetic patients.

Authors:  Masoumeh Shirzaiy; Fatemeh Heidari; Zohreh Dalirsani; Javid Dehghan
Journal:  Diabetes Metab Syndr       Date:  2013-03-14

5.  Xerostomia and salivary levels of glucose and urea in patients with diabetes.

Authors:  K Ivanovski; V Naumovski; M Kostadinova; S Pesevska; K Drijanska; V Filipce
Journal:  Prilozi       Date:  2012

6.  Estimation of salivary flow rate, pH, buffer capacity, calcium, total protein content and total antioxidant capacity in relation to dental caries severity, age and gender.

Authors:  Pallavi Pandey; N Venugopal Reddy; V Arun Prasad Rao; Aditya Saxena; C P Chaudhary
Journal:  Contemp Clin Dent       Date:  2015-03

7.  Salivary profile in diabetic patients: biochemical and immunological evaluation.

Authors:  Monica Virginia Viegas Lima-Aragão; João de Jesus de Oliveira-Junior; Márcia Cristina Gonçalves Maciel; Lucilene Amorim Silva; Flávia Raquel Fernandes do Nascimento; Rosane Nassar Meireles Guerra
Journal:  BMC Res Notes       Date:  2016-02-16

8.  Prevalence of diabetes in Northern African countries: the case of Tunisia.

Authors:  Habiba Ben Romdhane; Samir Ben Ali; Wafa Aissi; Pierre Traissac; Hajer Aounallah-Skhiri; Souha Bougatef; Bernard Maire; Francis Delpeuch; Noureddine Achour
Journal:  BMC Public Health       Date:  2014-01-28       Impact factor: 3.295

9.  Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study.

Authors:  Taye Jemilat Lasisi; Yemi Raheem Raji; Babatunde Lawal Salako
Journal:  BMC Nephrol       Date:  2016-01-16       Impact factor: 2.388

10.  Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy.

Authors:  Durmuş Ayan; Mehmet Şeneş; Ayşe Banu Çaycı; Sibel Söylemez; Nezaket Eren; Yüksel Altuntaş; Feyza Yener Öztürk
Journal:  J Med Biochem       Date:  2019-03-26       Impact factor: 3.402

View more
  4 in total

Review 1.  Salivary Biomarkers Associated with Psychological Alterations in Patients with Diabetes: A Systematic Review.

Authors:  Guillermo Bargues-Navarro; Vanessa Ibáñez-Del Valle; Nisrin El Mlili; Omar Cauli
Journal:  Medicina (Kaunas)       Date:  2022-08-12       Impact factor: 2.948

2.  Changes in salivary biomarkers associated with periodontitis and diabetic neuropathy in individuals with type 1 diabetes.

Authors:  Larissa Steigmann; Shogo Maekawa; Frederic Kauffmann; Jacob Reiss; Ashley Cornett; James Sugai; Julian Venegas; Xudong Fan; Yuying Xie; William V Giannobile; Rodica Pop-Busui; Isabelle M A Lombaert
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

3.  Salivary alpha-amylase-biomarker for monitoring type II diabetes.

Authors:  Vandana S Shah; Dishant Pareikh; Bhari S Manjunatha
Journal:  J Oral Maxillofac Pathol       Date:  2022-01-11

4.  Implication of Salivary Biochemical Parameters for Diagnosis and Prognosis of Type 2 Diabetes Mellitus.

Authors:  Sneha Shrestha; Sushant Pokhrel; Anjali Poudel; Shristi Bhandari Bc; Mudita Shakya; Alaska Timilsina; Manisha Sapkota; Bashu Dev Pardhe
Journal:  Int J Anal Chem       Date:  2022-08-10       Impact factor: 1.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.